ARCHIVES

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 03 | January 21, 2011

Download PDF Visit The Full Archive

Related Articles

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals

September 9, 1977

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987